Multiply Labs
PrivateLast Round
Series B
Oct 6, 2026
Est. Valuation
$60M
Total Funding Raised
$118.42M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Multiply Labs is a biotechnology company that creates advanced robotics technology for the production of personalized pharmaceutical capsules and cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Industrial Robotics, Biotech Equipment, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Multiply Labs Comparables
Compare Multiply Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ori Biotech | 89% | |
| Cellular Origins | 89% | |
| Celltrio | 82% |
Multiply Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 6, 2026 | ||||
| Early Funding | Mar 18, 2026 | ||||
| Series A Extension | Apr 21, 2023 | ||||
| Series A | Apr 14, 2021 | ||||
| Seed | May 2, 2017 | ||||
Accelerator | Aug 20, 2016 |
Multiply Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Strange Ventures | Series B |
| Lingotto | Series B |
| NantWorks | Series B |
| Founders Fund | Series A, Series B |
| Lux Capital | Series A, Series B |
| Teradyne Robotics Ventures | Series B |
| Garage Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 6, 2026
$75M round led by NantWorks.
- Jul 29, 2026
Grew 18% QoQ, from 67 to 79 employees.
Recent news
Latest coverage and updates
- receives_financingOct 6, 2026
Multiply Labs closed a $75M Series B in California on Oct 6th '26 to automate the manufacturing of complex biologics and gene therapies.
Multiply Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Multiply Labs's valuation, stock price, and market status.
Is Multiply Labs a public or private company?
Multiply Labs is a private company.
What is the current stock price of Multiply Labs?
Multiply Labs is a private company, so its shares have no public market price. Caplight tracks Multiply Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Multiply Labs worth (valuation)?
Multiply Labs's valuation is estimated at $60.0M based on funding round data.
Can I buy Multiply Labs stock?
Multiply Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Multiply Labs's last funding round?
Multiply Labs's most recent funding round was Series B on October 6, 2026.
Who are the main investors in Multiply Labs?
Key investors in Multiply Labs include NantWorks, Y Combinator, Casdin Capital, P101, Mayfield Fund.
Will Multiply Labs IPO soon?
No public IPO plans have been announced for Multiply Labs.
How can I track Multiply Labs secondary market activity?
Caplight tracks bids, offers, and trades in Multiply Labs's shares on secondary markets.